SCHEMBL573735

SCHEMBL573735

CCCCCCC(C)(CC)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.44
GPR84 Q9NQS5 7/20 0.43
PPARG P37231 7/20 0.43
PPARD Q03181 7/20 0.43
PPARA Q07869 7/20 0.43
HDAC11 Q96DB2 5/20 0.43
TSHR P16473 4/20 0.43
PTPN1 P18031 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
MEN1 O00255 1/20 0.43
ESR1 P03372 1/20 0.43
ALOX15 P16050 1/20 0.43
PDE4A P27815 1/20 0.43
KMT2A Q03164 1/20 0.43
PDE3A Q14432 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13840980 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL4649165 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL1704718 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL9932880 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL5879070 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL20936468 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL20915491 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL20915417 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
SCHEMBL20915246 1.00 CES2 (0.44) CES2GPR84PPARGPPARDPPARA
Ammonia Solution, Strong SCHEMBL28708430 0.98 CES2 (0.42) CES2GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111533831-A Method for removing residual metal after hydrogenation of unsaturated polymer 浙江众立合成材料科技股份有限公司 2020-08-14 CN claimed
EP-3687968-A1 NEO-ACIDS AND PROCESS FOR MAKING THE SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP claimed
EP-3010555-B1 ABSORBENT ARTICLE COMPRISING COMPLEXED OR ENCAPSULATED REACTIVE COMPOUNDS PROCTER & GAMBLE (US) 2020-07-15 EP claimed
CN-111328326-A Neo-acids and process for their preparation 埃克森美孚化学专利公司 2020-06-23 CN claimed
CN-110327483-A Absorbent article comprising compound or encapsulating reactive compound 宝洁公司 2019-10-15 CN claimed
US-20190100483-A1 Neo-Acids and Process for Making the Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US claimed
WO-2019067063-A1 NEO-ACIDS AND PROCESS FOR MAKING THE SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-04 WO claimed
EP-2152437-B1 RADIATION CURABLE INKS COLLINS INK CORP (US) 2014-11-26 EP claimed
US-20140135297-A1 AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION ISP INVESTMENTS INC. (US) 2014-05-15 US claimed
WO-2012170841-A1 AN AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION ISP INVESTMENTS INC. (US) 2012-12-13 WO claimed
WO-2008045478-A1 RADIATION CURABLE INKJETTABLE ADHESIVE HEXION SPECIALTY CHEMICALS, INC. (US) 2008-04-17 WO claimed
WO-2008045480-A1 RADIATION CURABLE INKS HEXION SPECIALTY CHEMICALS, INC. (US) 2008-04-17 WO claimed
US-20080090930-A1 Photocation polymerization initiator, a free-radical photoinitiator; an acrylate ester of a carboxylic acid ester; and material containing a radiation curable functional group; imppulse printheads HEXION SPECIALTY CHEMICALS, INC. 2008-04-17 US claimed
US-20080090932-A1 Radiation curable inkjettable adhesive HEXION SPECIALTY CHEMICALS, INC. 2008-04-17 US claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
EP-1708570-A2 COMPOSITION AND USE THEREOF AS ATTRACTANT FOR THE GARDEN CHAFER i (PHYLLOPERTHA HORTICOLA) /i Freie Universität Berlin (DE) 2006-10-11 EP claimed
WO-2005072526-A2 COMPOSITION AND USE THEREOF AS ATTRACTANT FOR THE GARDEN CHAFER (PHYLLOPERTHA HORTICOLA) FREIE UNIVERSITÄT BERLIN (DE) 2005-08-11 WO claimed
WO-1990002111-A1 PLATINUM COMPLEXES OF SINGLE ISOMER NEOALKYL ACIDS THE LIPOSOME COMPANY, INC. (US) 1990-03-08 WO claimed
EP-0356332-A2 Platinum complexes of single isomer neoalkyl acids THE LIPOSOME COMPANY, INC. (US) 1990-02-28 EP claimed
US-4250200-A Flavoring with a mixture of isochroman musk compounds INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1981-02-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190100483-A1 Neo-Acids and Process for Making the Same COASY, ELOVL6, ELOVL1 CES2 615/4885GPR84 1101/4885PPARG 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.